Skip to content

BIO

BIO-RAD LABORATORIES, INC.

NYSE · Healthcare · Medical - Devices · US

$376.41
−1.57%
Ask drillr

Next report

Analyst consensus

Next report date
Oct 29, 2026
EPS estimate
$2.23
Revenue estimate
$651.2M

Latest reported

Last report date
Aug 4, 2026
EPS actual
$2.62
EPS estimate
$1.76
Revenue actual
$651.0M
Revenue estimate
$626.0M

Track record

Trailing twelve quarters

EPS beats (12Q)
8
EPS misses (12Q)
4
EPS in line (12Q)
0
Avg surprise (4Q)
+9.9%
Revenue beats (12Q)
4

Analyst ratings

Sell-side consensus

Consensus
Hold
Price target
$350
PT range
$330 – $390
Analysts
3
1 Buy2 Hold0 Sell
Reported history
Report dateEPS estimateEPS actualSurpriseRevenue actual
Aug 4, 2026$1.76$2.62Beat 48.78%$651.0M
Apr 30, 2026$1.99$1.89Miss -5.03%$592.1M
Feb 12, 2026$2.57$2.51Miss -2.33%$693.2M
Oct 29, 2025$2.30$2.26Miss -1.74%$653.0M
Jul 31, 2025$1.93$2.61Beat 35.23%$651.6M
May 1, 2025$1.73$2.54Beat 46.82%$585.4M
Feb 13, 2025$2.86$2.90Beat 1.40%$667.5M
Oct 30, 2024$1.28$2.01Beat 57.03%$649.7M
Aug 1, 2024$2.12$3.11Beat 46.70%$638.5M
Feb 15, 2024$2.93$3.10Beat 5.87%$681.2M
Oct 26, 2023$2.85$2.33Miss -18.36%$632.1M
Aug 3, 2023$2.55$3.00Beat 17.46%$681.1M

Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Oct 29, 2026